Investors

Discover Virbac's Statement on extra-financial performance

SALES 2023
1,247 M€
59%
Companion
animals
41%
Farm
animals

(in € million)

Financial public release
& News

2024 fourth quarter consolidated sales

2025/01/16 - Financial public releases

Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)

Read more

Türkiye: Virbac acquires its companion animal products distributor

2024/12/03 - Financial public releases

Vignette_corpo_Byzance.jpgOn December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products.

Read more

2024 third quarter consolidated sales

2024/10/17 - Financial public releases

Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

Read more

Events
Thursday March 13

2024 results

From 2025/03/13

Read moreRead less

Thursday March 13, 2024 after market close

2024 results
(quiet period from February 13, 2025)​

Friday March 14

SFAF meeting - 2024 financial & strategic information

From 2025/03/14

Read moreRead less

Friday March 14, 2025
SFAF meeting - 2024 financial & strategic information
Tuesday April 15

2025 first quarter sales

From 2025/04/15

Read moreRead less

Tuesday April 15, 2025 after market close

2025 first quarter sales
(quiet period from April 1, 2024)

Past Events
Thursday January 16

2024 fourth quarter year sales

From 2025/01/16

Read moreRead less

Thursday January 16, 2024 after market close

2024 fourth quarter year sales
(quiet period from January 2, 2025)

For more financial information

For more financial information

finances@virbac.com